Oclacitinib Impurity 21 CAS 1208319-28-1

Purity ≥95%In StockPharmacopoeial Impurity Standards
CAS No.1208319-28-1
Molecular FormulaC22H29N5O4S2
Molecular Weight491.63 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Oclacitinib Impurity 21 CAS 1208319-28-1 chemical structure

Description

CATO supplies Oclacitinib Impurity 21 (CAS 1208319-28-1), a pharmacopoeial impurity reference standard (molecular formula C22H29N5O4S2, MW 491.63 g/mol) used for the identification and quantification of trace impurities in APIs.

Owing to a flavonoid core, an amide group, a sulfone group, a hydroxyl group, an ether linkage, Oclacitinib Impurity 21 is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 491.63 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

As a certified reference material (CRM), Oclacitinib Impurity 21 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Molecular FormulaC22H29N5O4S2
Molecular Weight491.63 g/mol
Purity≥95%
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)11.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1990
Nitrogen Atoms5
Sulfur Atoms2

Related Oclacitinib Standards

Recommended Standards

Why CATO?